- Home
- CHEF vs TARS Comparison
CHEF vs TARS Comparison
Compare CHEF & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHEF | TARS |
|---|---|---|
| Founded | 1985 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.8B |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHEF | TARS |
|---|---|---|
| Price | $63.57 | $68.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 9 |
| Target Price | $74.00 | ★ $76.56 |
| AVG Volume (30 Days) | 425.9K | ★ 624.5K |
| Earning Date | 02-11-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.09 | N/A |
| EPS | ★ 1.73 | N/A |
| Revenue | ★ $4,040,541,000.00 | $366,100,000.00 |
| Revenue This Year | $10.35 | $147.34 |
| Revenue Next Year | $7.21 | $53.50 |
| P/E Ratio | $36.97 | ★ N/A |
| Revenue Growth | 8.88 | ★ 182.44 |
| 52 Week Low | $45.00 | $38.51 |
| 52 Week High | $68.94 | $85.25 |
Technical Indicators
Market Signals| Indicator | CHEF | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 21.95 |
| Support Level | $62.31 | $69.46 |
| Resistance Level | $66.30 | $73.82 |
| Average True Range (ATR) | 2.64 | 2.89 |
| MACD | 0.20 | -1.02 |
| Stochastic Oscillator | 67.56 | 5.40 |
Price Performance
Historical ComparisonAbout CHEF The Chefs' Warehouse Inc.
The Chefs' Warehouse Inc is a specialty food distributor in metropolitan areas across the United States and Canada. The company's product portfolio is comprised of imported and local specialty food products such as cheese, cooking oils, chocolates, dried food, baking products, meats, and other food products. It operates via one reporting segment called Food Product Distribution. Operations are concentrated on the east, midwest, and west coasts of the U.S. The company provides service to restaurants, clubs, hotels, caterers, schools, bakeries, casinos, and specialty food stores.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.